Organization Overview
Historical Acquisition Tree
Alternative names
Key: Sumitomo Dainippon (1) Acquired (1)
alcaftadine (Lastacaft) (2010)
lurasidone (latuda) (2010 NDA)
Key: Sumitomo Dainippon (0) Acquired (24)
albuterol (proventil) (16 trials)
arformoterol (brovana) (16 trials)
arotinolol hydrochloride (2 trials)
ciclesonide (alvesco) (13 trials)
escitalopram (lexapro) (1 trial)
eslicarbazepine acetate (aptiom) (7 trials)
Key: Sumitomo Dainippon (3) Acquired (29)
apomorphine (apokyn) (2 trials)
bevacizumab (avastin) (5 trials)
cisplatin (platinol) (2 trials)
fluorouracil (efudex) (5 trials)
formoterol (foradil) (2 trials)
gemcitabine (gemzar) (3 trials)
icosapent ethyl (vascepa) (1 trial)
Key: Sumitomo Dainippon (3) Acquired (35)
aclidinium (tudorza pressair) (1 trial)
azacitidine (vidaza) (1 trial)
capecitabine (xeloda) (3 trials)
cytarabine (cytosar-u) (4 trials)
glycopyrronium (robinul) (3 trials)
ibrutinib (imbruvica) (2 trials)
ipilimumab (yervoy) (2 trials)
ipratropium (atrovent) (2 trials)
Key: Sumitomo Dainippon (3) Acquired (23)
abiraterone (zytiga) (1 trial)
aripiprazole (abilify) (2 trials)
atezolizumab (tecentriq) (1 trial)
Key: Sumitomo Dainippon (0) Acquired (6)
Anemia (Phase 2)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Bipolar Disorder (Phase 3)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Colorectal Neoplasms (Phase 2)
Depression (Phase 3)
Depressive Disorder (Phase 3)
Diabetic Neuropathies (Phase 3)
Disease (Phase 3)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Hepatoblastoma (Phase 1)
Leukemia (Phase 1)
Leukemia, Myeloid (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Lung Neoplasms (Phase 3)
Medulloblastoma (Phase 1)
Mesothelioma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Neoplasms (Phase 1)
Neuroblastoma (Phase 1)
Polyneuropathies (Phase 3)
Preleukemia (Phase 2)
Rhabdomyosarcoma (Phase 1)
Rhinitis (Phase 1)
Rhinitis, Allergic (Phase 1)
Rhinitis, Allergic, Seasonal (Phase 1)
Sarcoma (Phase 1)
Sarcoma, Ewing (Phase 1)
Schizophrenia (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Syndrome (Phase 2)
Urinary Bladder, Overactive (Phase 2)